Works by Sullivan, Ryan

Results: 242
    1
    2
    3
    4
    5
    6

    Relapse-free survival with adjuvant dabrafenib/trametinib therapy after relapse on a prior adjuvant CPI in BRAF V600-mutated stage III/IV melanoma.

    Published in:
    Oncologist, 2025, v. 30, n. 3, p. 1, doi. 10.1093/oncolo/oyae289
    By:
    • Weber, Jeffrey;
    • Haque, Waqas;
    • Markovic, Svetomir N;
    • Salama, April K S;
    • Mehmi, Inderjit;
    • Sullivan, Ryan J;
    • Najjar, Yana G;
    • Akkooi, Alexander C J van;
    • Menzies, Alexander M;
    • Long, Georgina V;
    • Taylor, Amelia M;
    • Haanen, John;
    • Zijlker, Lisanne P;
    • Davis, Keith L;
    • Karanth, Siddharth;
    • Norton, Deborah;
    • Connolly, Lucy
    Publication type:
    Article
    7

    Phase II Study of Cabozantinib in Patients With Bone Metastasis.

    Published in:
    Oncologist, 2022, v. 27, n. 7, p. 600, doi. 10.1093/oncolo/oyac083
    By:
    • Choy, Edwin;
    • Cote, Gregory M;
    • Michaelson, M Dror;
    • Wirth, Lori;
    • Gainor, Justin F;
    • Muzikansky, Alona;
    • Sequist, Lecia V;
    • Sullivan, Ryan J;
    • Fidias, Panagiotis M;
    • Shaw, Alice;
    • Heist, Rebecca S
    Publication type:
    Article
    8
    9
    10

    Temporal Trends in Inpatient Oncology Census Before and During the COVID‐19 Pandemic and Rates of Nosocomial COVID‐19 Among Patients with Cancer at a Large Academic Center.

    Published in:
    Oncologist, 2021, v. 26, n. 8, p. e1427, doi. 10.1002/onco.13807
    By:
    • Zubiri, Leyre;
    • Rosovsky, Rachel P.;
    • Mooradian, Meghan J.;
    • Piper‐Vallillo, A.J.;
    • Gainor, Justin F.;
    • Sullivan, Ryan J.;
    • Marte, Daniel;
    • Boland, Genevieve M.;
    • Gao, Xin;
    • Hochberg, Ephraim P.;
    • Ryan, David P.;
    • McEwen, Corey;
    • Mai, Minh;
    • Sharova, Tanya;
    • Soumerai, Tara E.;
    • Bardia, Aditya;
    • Reynolds, Kerry L.
    Publication type:
    Article
    11
    12
    13

    Upfront Surgical Resection of Melanoma Brain Metastases Provides a Bridge Toward Immunotherapy‐Mediated Systemic Control.

    Published in:
    Oncologist, 2019, v. 24, n. 5, p. 671, doi. 10.1634/theoncologist.2018-0306
    By:
    • Alvarez‐Breckenridge, Christopher;
    • Giobbie‐Hurder, Anita;
    • Gill, Corey M.;
    • Bertalan, Mia;
    • Stocking, Jackson;
    • Kaplan, Alexander;
    • Nayyar, Naema;
    • Lawrence, Donald P.;
    • Flaherty, Keith T.;
    • Shih, Helen A.;
    • Oh, Kevin;
    • Batchelor, Tracy T.;
    • Cahill, Daniel P.;
    • Sullivan, Ryan;
    • Brastianos, Priscilla K.
    Publication type:
    Article
    14
    15

    Impact of Age on Outcomes with Immunotherapy for Patients with Melanoma.

    Published in:
    Oncologist, 2017, v. 22, n. 8, p. 963, doi. 10.1634/theoncologist.2016-0450
    By:
    • Betof, Allison S.;
    • Nipp, Ryan D.;
    • Giobbie‐Hurder, Anita;
    • Johnpulle, Romany A. N.;
    • Rubin, Krista;
    • Rubinstein, Samuel M.;
    • Flaherty, Keith T.;
    • Lawrence, Donald P.;
    • Johnson, Douglas B.;
    • Sullivan, Ryan J.
    Publication type:
    Article
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36

    HIV-associated multicentric Castleman's disease.

    Published in:
    American Journal of Hematology, 2008, v. 83, n. 6, p. 498, doi. 10.1002/ajh.21137
    By:
    • Stebbing, Justin;
    • Pantanowitz, Liron;
    • Dayyani, Farshid;
    • Sullivan, Ryan J.;
    • Bower, Mark;
    • Dezube, Bruce J.
    Publication type:
    Article
    37
    38

    Clinical features of acute kidney injury in patients receiving dabrafenib and trametinib.

    Published in:
    Nephrology Dialysis Transplantation, 2022, v. 37, n. 3, p. 507, doi. 10.1093/ndt/gfaa372
    By:
    • Seethapathy, Harish;
    • Lee, Meghan D;
    • Strohbehn, Ian A;
    • Efe, Orhan;
    • Rusibamayila, Nifasha;
    • Chute, Donald F;
    • Colvin, Robert B;
    • Rosales, Ivy A;
    • Fadden, Riley M;
    • Reynolds, Kerry L;
    • Sullivan, Ryan J;
    • Kaufman, Howard L;
    • Jhaveri, Kenar D;
    • Sise, Meghan E
    Publication type:
    Article
    39

    A Phase I Trial of Bortezomib and Sorafenib in Advanced Malignant Melanoma.

    Published in:
    Oncologist, 2015, v. 20, n. 6, p. 617, doi. 10.1634/theoncologist.2015-0105
    By:
    • Sullivan, Ryan J.;
    • Ibrahim, Nageatte;
    • Lawrence, Donald P.;
    • Aldridge, Julie;
    • Giobbie‐Hurder, Anita;
    • Hodi, F. Stephen;
    • Flaherty, Keith T.;
    • Conley, Christine;
    • Mier, James W.;
    • Atkins, Michael B.;
    • McDermott, David F.
    Publication type:
    Article
    40

    Ipilimumab for Patients With Advanced Mucosal Melanoma.

    Published in:
    Oncologist, 2013, v. 18, n. 6, p. 726, doi. 10.1634/theoncologist.2012-0464
    By:
    • Postow, Michael A.;
    • Luke, Jason J.;
    • Bluth, Mark J.;
    • Ramaiya, Nikhil;
    • Panageas, Katherine S.;
    • Lawrence, Donald P.;
    • Ibrahim, Nageatte;
    • Flaherty, Keith T.;
    • Sullivan, Ryan J.;
    • Ott, Patrick A.;
    • Callahan, Margaret K.;
    • Harding, James J.;
    • D'Angelo, Sandra P.;
    • Dickson, Mark A.;
    • Schwartz, Gary K.;
    • Chapman, Paul B.;
    • Gnjatic, Sacha;
    • Wolchok, Jedd D.;
    • Hodi, F. Stephen;
    • Carvajal, Richard D.
    Publication type:
    Article
    41
    42
    43

    Passively sensing smartphone use in teens with rates of use by sex and across operating systems.

    Published in:
    Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-68467-8
    By:
    • Alexander, Jordan D.;
    • Linkersdörfer, Janosch;
    • Toda-Thorne, Katherine;
    • Sullivan, Ryan M.;
    • Cummins, Kevin M.;
    • Tomko, Rachel L.;
    • Allen, Nicholas B.;
    • Bagot, Kara S.;
    • Baker, Fiona C.;
    • Fuemmeler, Bernard F.;
    • Hoffman, Elizabeth A.;
    • Kiss, Orsolya;
    • Mason, Michael J.;
    • Nguyen-Louie, Tam T.;
    • Tapert, Susan F.;
    • Smith, Calen J.;
    • Squeglia, Lindsay M.;
    • Wade, Natasha E.
    Publication type:
    Article
    44

    STAG2 regulates interferon signaling in melanoma via enhancer loop reprogramming.

    Published in:
    Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-29541-9
    By:
    • Chu, Zhaowei;
    • Gu, Lei;
    • Hu, Yeguang;
    • Zhang, Xiaoyang;
    • Li, Man;
    • Chen, Jiajia;
    • Teng, Da;
    • Huang, Man;
    • Shen, Che-Hung;
    • Cai, Li;
    • Yoshida, Toshimi;
    • Qi, Yifeng;
    • Niu, Zhixin;
    • Feng, Austin;
    • Geng, Songmei;
    • Frederick, Dennie T.;
    • Specht, Emma;
    • Piris, Adriano;
    • Sullivan, Ryan J.;
    • Flaherty, Keith T.
    Publication type:
    Article
    45
    46
    47
    48
    49
    50